Daily Summary of Health · Final editionTuesday 17 November 2026 · UTC
Health News: 17 November 2026
US loses measles elimination status as FDA approves rare disease and breast cancer drugs
The US lost measles elimination status after more than 5,400 cases and eight deaths in 2026, with endemic transmission also re-established in Mexico and Bolivia. The FDA approved Lembaz, the first treatment shown to reduce death risk in infantile-onset Niemann-Pick disease type C, and giredestrant with everolimus for ESR1-mutated advanced breast cancer.
The UN also warned that hormone-disrupting chemicals in everyday items are a growing health threat.
UN warns hormone-disrupting chemicals pose growing health threat
The United Nations said Tuesday that hormone-disrupting chemicals in everyday items are a growing threat to human health and the environment. The substances, detected in breast milk and umbilical cord blood, can disrupt hormones during early exposure and have lasting effects on brain development, growth and reproductive health. Two UN bodies called for urgent international action, saying current policies remain fragmented and insufficient.
FDA approves first drug shown to reduce death risk in infantile NPC
FDA approved Lembaz (adrabetadex) injection for adults and children weighing at least 7 kg with Niemann-Pick disease type C whose neurological symptoms began before age 6. It is the first treatment shown to reduce the risk of death in this severe, inherited form, which affects an estimated 1 in 150,000 people. Among 36 treated patients, median survival was 8.5 years versus 4.9 years in a matched control group, with a 55% lower risk of death.
EMA issues EU 2026/2027 flu vaccine recommendations without B/Yamagata
EMA has recommended the influenza strains for EU seasonal vaccines for the 2026/2027 season, to keep vaccines effective as influenza viruses evolve. It recommends no B/Yamagata strain because the virus has not been detected in circulation since March 2020. EMA recommends that marketing authorisation holders submit applications to change the composition of centrally authorised seasonal influenza vaccines by 15 June 2026.
US loses measles elimination status after worst outbreak since 1991
International health officials said Tuesday that measles is no longer eliminated in the United States, ending a status first granted in 2000. The Pan American Health Organization said endemic transmission has been re-established in the US, Mexico and Bolivia, as the US recorded more than 5,400 cases and eight deaths in 2026. CDC said it will encourage MMR vaccination and has invested $100 million to regain the status.
Gene therapy death investigation points to future screening tests
Researchers presented detailed investigations into a gene therapy death in a brain disease trial that had raised concerns among scientists. They did not identify the exact cause but proposed experiments to screen future therapies for a novel risk. Capsida Biotherapeutics chief research and innovation officer Nicholas Flytzanis said the team is building a framework to test and mitigate that risk.
Philip Morris International introduced mint-flavored Zyn Melts in the UK and Switzerland, while Japan Tobacco International launched Perlz in the UK in May. In the US, Nic Nac Naturals has sold flavored Nic Nac lozenges since 2022, with products in about 3,000 stores. Public health advocates say mint-like tablets may look harmless and appeal to children and adolescents, but the FDA has authorized similar products as less harmful than cigarettes.
Health secretary Kennedy seeks federal funding for faith-based addiction recovery
Health secretary Robert F. Kennedy Jr. called Sheepgate, an addiction recovery center in Iowa, a model for faith-based programs he wants to receive federal funding. The administration has highlighted such programs in its 2026 National Drug Control Strategy and Great American Recovery Initiative. Experts say faith can aid recovery, but some worry grants may reach centers that limit evidence-based opioid medications, as Sheepgate bars methadone.
German study: current booster antibodies neutralize SARS-CoV-2 variant PJ.2.1
German researchers found that the new SARS-CoV-2 variant PJ.2.1 binds more strongly to the ACE2 receptor and enters cells that produce small amounts of ACE2 more effectively than other variants studied. Antibodies from the current booster vaccine, adapted to the XFG variant, effectively neutralized PJ.2.1, suggesting vaccination provides protection. The variant has spread since May and could change if it gains further immune evasion mutations.
Welsh government plan aims to end A&E corridor care by 2029
A £23m Welsh government plan aims to end A&E corridor care by 2029, after a 63-year-old patient said he waited more than 50 hours in the same chair at Royal Glamorgan Hospital on two visits. The plan cites ambulance delays, long waits for older patients and 62,346 emergency admissions staying more than 21 days. Cwm Taf Morgannwg health board said it was sorry for the patient's distress.
Tirzepatide trial finds 54% of treated teens below obesity threshold
A Phase III trial of once-weekly tirzepatide in 160 teenagers with obesity or overweight and related complications found average BMI fell 18.5% after 72 weeks, versus a 0.5% rise with placebo. About 54% of treated teens fell below the obesity threshold for their age and sex, compared with 7% of placebo recipients. The study, published in JAMA, also reported better blood markers, physical comfort and quality-of-life measures.
Nursing union criticises Northern Ireland safe staffing bill
The Royal College of Nursing says it is extremely dissatisfied with Northern Ireland's proposed Health and Social Care (Staffing) bill, which would put workforce planning on a statutory footing. RCN director Rita Devlin said the draft does not reflect co-design work since 2020, omits safe staffing from its title and lacks guiding principles. The union wants accountability for workforce planning to remain solely with the Department of Health.
EU-backed Genome of Europe project to map 100,000 genomes
The Genome of Europe programme will create a shared reference base of at least 100,000 human genomes from 49 partners in 27 European countries. The €45 million project, funded in part by €20 million from the European Commission, began in autumn 2024 and will run for 3.5 years. Its aim is to capture European genetic diversity for personalised medicine and research.
Encouraging sick college students to isolate may reduce flu spread
A Wake Forest analysis of the eX-FLU trial found that encouraging college students with flu-like illness to isolate for three days may reduce the spread of respiratory infection. The study used data from what is believed to be the largest randomized trial tracking respiratory infection transmission through a social network. Researchers said the low-cost approach could offer an alternative to mandatory distancing during outbreaks.
Stanford study finds genetic clues in recurrent miscarriages
Stanford Medicine researchers and collaborators found possible genetic explanations in 30 of 118 families with recurrent unexplained miscarriages. They sequenced the genomes of parents and miscarried pregnancies, identifying pathogenic or likely pathogenic variants in 18 families and variants of uncertain significance in 12. In 24 of the 30 families, at least one parent carried a variant, suggesting inherited changes may explain recurrence.
Kidney protein found to regulate phosphate and protect vessels
University of Colorado Anschutz School of Medicine researchers identified a kidney protein that helps balance blood phosphate levels. In animal models, deficiency of the protein accelerated blood vessel stiffening and shortened life expectancy, especially with a high phosphate diet, while a lower phosphate diet lessened some effects. The protein may become a target for treatments aimed at phosphate balance in chronic kidney disease.
Extended lymph node dissection shows no higher 30-day risk in stage IV gastric cancer
A study of 855 patients with stage IV gastric cancer after palliative gastrectomy found that retrieving 15 or more lymph nodes was not linked to higher 30-day complications or death. Before adjustment, the limited group had higher complication and mortality rates, but included more patients in poorer health and more open or total gastrectomies. Researchers said the observational results do not prove extended dissection is safer or beneficial.
Uterine bacteria may influence IVF success, study finds
Researchers from Trinity College Dublin analyzed endometrial tissue from 29 women with unexplained infertility before assisted reproductive treatment. Women who did not achieve pregnancy had a more diverse uterine microbiome than those who did, suggesting bacteria in the uterine lining may affect IVF success. The study used DNA sequencing rather than culturing living bacteria, and the existence of a stable uterine microbiome remains unproven.
England measles outbreak linked to falling MMR coverage
A surveillance study of 2,821 confirmed measles cases from October 2023 to September 2024 found 92.5 percent had no recorded MMR vaccination. Many infections involved young children in more deprived urban areas, and more than a third of cases with linked records were admitted to hospital.
The UK later lost measles elimination status after over a year of sustained transmission, amid first MMR dose coverage of 88.9 percent by 24 months in 2023 to 2024.
Review weighs salt, diet, exercise and caffeine for blood pressure
A review by US researchers in Current Hypertension Reports found that calorie restriction and the DASH diet, especially with regular physical activity, can lower blood pressure, while evidence for time restricted eating is less conclusive. It also noted that reducing caffeine and alcohol and avoiding cocaine, methamphetamine and some herbal supplements may help.
Maternal nanoplastic exposure reduced ovarian follicles in newborn mice
A study in Communications Biology found that pregnant mice given polystyrene nanoplastics orally from embryonic day 16.5 had female offspring with disrupted primordial follicle assembly and reduced ovarian reserve. Researchers used eight mice per group and collected ovaries at postnatal days 0, 3 and 7. Because mothers in the day 3 group kept receiving nanoplastics after birth, changes at that age cannot be attributed solely to prenatal exposure.